Charles Schwab’s Vascular Solutions Inc VASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-69,755
| Closed | -$3.91M | – | 3093 |
|
|
2016
Q4 | $3.91M | Sell |
69,755
-4,201
| -6% | -$214K | ﹤0.01% | 1871 |
|
|
2016
Q3 | $3.57M | Buy |
73,956
+14,510
| +24% | +$676K | ﹤0.01% | 1852 |
|
|
2016
Q2 | $2.48M | Buy |
59,446
+1,194
| +2% | +$44.4K | ﹤0.01% | 1957 |
|
|
2016
Q1 | $1.9M | Buy |
58,252
+1,323
| +2% | +$38.1K | ﹤0.01% | 2082 |
|
|
2015
Q4 | $1.96M | Buy |
56,929
+1,892
| +3% | +$64.1K | ﹤0.01% | 2091 |
|
|
2015
Q3 | $1.78M | Buy |
55,037
+10,164
| +23% | +$364K | ﹤0.01% | 2132 |
|
|
2015
Q2 | $1.56M | Buy |
44,873
+1,394
| +3% | +$45.5K | ﹤0.01% | 2213 |
|
|
2015
Q1 | $1.32M | Buy |
43,479
+1,972
| +5% | +$56.6K | ﹤0.01% | 2267 |
|
|
2014
Q4 | $1.13M | Buy |
41,507
+1,037
| +3% | +$28.2K | ﹤0.01% | 2294 |
|
|
2014
Q3 | $1M | Buy |
40,470
+5,247
| +15% | +$124K | ﹤0.01% | 2299 |
|
|
2014
Q2 | $782K | Sell |
35,223
-256
| -0.7% | -$5.6K | ﹤0.01% | 2437 |
|
|
2014
Q1 | $930K | Buy |
35,479
+960
| +3% | +$23.9K | ﹤0.01% | 2325 |
|
|
2013
Q4 | $800K | Buy |
34,519
+1,152
| +3% | +$22.6K | ﹤0.01% | 2379 |
|
|
2013
Q3 | $555K | Buy |
33,367
+1,552
| +5% | +$25.1K | ﹤0.01% | 2512 |
|
|
2013
Q2 | $464K | Buy |
+31,815
| New | +$500K | ﹤0.01% | 2555 |
|
Other funds holding VASC
Charles Schwab's VASC Position: Q1 2017 in Review
Charles Schwab sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 69,755 shares — an estimated $3.91M sold.
Charles Schwab first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $3.91M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.
- Charles Schwab reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
- Charles Schwab sold 69,755 Vascular Solutions Inc shares in Q1 2017, an estimated $3.91M.
- Charles Schwab first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
- Charles Schwab's Vascular Solutions Inc position peaked at $3.91M in Q4 2016.
- 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.
Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.